Literature DB >> 3256

Endocrine and metabolic diseases. Adrenal diseases.

G M Besser, W J Jeffcoate.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 3256      PMCID: PMC1638946          DOI: 10.1136/bmj.1.6007.448

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  12 in total

1.  Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease.

Authors:  Roberta Giordano; Federica Guaraldi; Elisa Marinazzo; Federica Fumarola; Alessia Rampino; Rita Berardelli; Ioannis Karamouzis; Manuela Lucchiari; Tilde Manetta; Giulio Mengozzi; Emanuela Arvat; Ezio Ghigo
Journal:  Endocrine       Date:  2015-07-17       Impact factor: 3.633

2.  Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets.

Authors:  Nicolas Simon; Frederic Castinetti; Floriane Ouliac; Nathalie Lesavre; Thierry Brue; Charles Oliver
Journal:  Clin Pharmacokinet       Date:  2010-07       Impact factor: 6.447

3.  Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion.

Authors:  A M Isidori; G Arnaldi; M Boscaro; A Falorni; C Giordano; R Giordano; R Pivonello; C Pozza; E Sbardella; C Simeoli; C Scaroni; A Lenzi
Journal:  J Endocrinol Invest       Date:  2019-11-26       Impact factor: 4.256

Review 4.  Dual-release Hydrocortisone in Addison's Disease - A Review of the Literature.

Authors:  Roberta Giordano; Federica Guaraldi; Rita Berardelli; Ioannis Karamouzis; Valentina D'Angelo; Clizia Zichi; Silvia Grottoli; Ezio Ghigo; Emanuela Arvat
Journal:  Eur Endocrinol       Date:  2014-02-28

Review 5.  Glucocorticoid effects on adiponectin expression.

Authors:  Siddharth Sukumaran; Debra C Dubois; William J Jusko; Richard R Almon
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

Review 6.  Aetiology, diagnosis, and management of hypopituitarism in adult life.

Authors:  V K B Prabhakar; S M Shalet
Journal:  Postgrad Med J       Date:  2006-04       Impact factor: 2.401

7.  Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study.

Authors:  Karina Danilowicz; Oscar Domingo Bruno; Marcos Manavela; Reynaldo Manuel Gomez; Ariel Barkan
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

8.  Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement.

Authors:  R Giordano; S Marzotti; M Balbo; S Romagnoli; E Marinazzo; R Berardelli; G Migliaretti; A Benso; A Falorni; E Ghigo; E Arvat
Journal:  J Endocrinol Invest       Date:  2009-07-20       Impact factor: 4.256

9.  Evaluation of two replacement regimens in primary adrenal insufficiency patients. effect on clinical symptoms, health-related quality of life and biochemical parameters.

Authors:  N Alonso; M L Granada; A Lucas; I Salinas; J Reverter; A Oriol; A Sanmarti
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

10.  Improvement of treatment of primary adrenal insufficiency by administration of cortisone acetate in three daily doses.

Authors:  S Laureti; A Falorni; F Santeusanio
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.